ANVS
Annovis Bio, Inc.
+0.09 (+8.65%)1.13USD694K成交股數48.1M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | 0.00 | – | – | – | 0.00 | – | – | 0.00 | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 12.0M | 16.7M | 8.8M | 6.3M | 5.2M | 5.0M | 2.7M | 5.8M | 6.5M | 8.9M | 13.8M | 8.3M |
| 銷售管理費用 | 2.4M | 1.3M | 955K | 1.1M | 1.1M | 1.3M | 1.7M | 2.0M | 1.3M | 1.5M | 1.0M | 1.5M |
| 營業利益 | −14.4M+129% | −18.0M+187% | −9.7M+121% | −7.4M-4% | −6.3M-20% | −6.3M-40% | −4.4M-70% | −7.8M-20% | −7.8M | −10.4M | −14.9M | −9.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −14.8M+138% | −17.6M+218% | −9.8M-22% | −7.3M+45% | −6.2M+483% | −5.5M-75% | −12.6M-14% | −5.0M-47% | −1.1M | −22.2M | −14.7M | −9.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.40+25% | -0.63+97% | -0.39-60% | -0.37-16% | -0.32-56% | -0.32-87% | -0.97-40% | -0.44-59% | -0.72 | -2.46 | -1.63 | -1.07 |
| 稀釋股數 | 37.5M | 27.8M | 20.6M | 19.7M | 19.5M | 17.4M | 13.0M | 11.3M | 10.8M | 9.0M | 9.0M | 9.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 18.7M | 14.2M | 19.5M | 15.3M | 17.1M | 22.2M | 12.6M | 4.0M | 3.1M | 5.8M | 6.4M | 15.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 22.0M | 16.2M | 21.1M | 17.2M | 21.5M | 26.7M | 14.4M | 5.0M | 7.8M | 10.2M | 10.2M | 22.8M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 26.3M | 13.1M | 4.2M | 4.0M | 3.1M | 2.7M | 7.3M | 6.8M | 11.2M | 18.0M | 3.6M | 2.1M |
| 股東權益 | −4.3M | 3.1M | 16.9M | 13.2M | 18.3M | 24.1M | 7.1M | −1.8M | −3.4M | −7.8M | 6.7M | 20.7M |
| 負債比 | 119.3% | 80.8% | 20.1% | 23.5% | 14.6% | 10.0% | 50.8% | 134.7% | 142.9% | 175.9% | 34.9% | 9.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −9.0M+11% | – | – | – | −8.1M | – | – | −7.0M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | −28.9M | –% | -1.40 | – |
| FY2024 | 0.00 | – | −24.6M | –% | -2.31 | – |
| FY2023 | 0.00 | – | −56.2M | –% | -6.23 | – |
| FY2022 | 0.00 | – | −25.3M | –% | -3.10 | – |
| FY2021 | 0.00 | – | −14.5M | –% | -1.90 | – |
| FY2020 | 0.00 | – | −5.5M | –% | -0.87 | – |
| FY2019 | 0.00 | – | −991K | –% | -3.51 | – |